| Application no. and date | 20214749.2 (espacenet) (Federated) (European Patent Register), 20160714 | | Patent/reg. no. and date | DK/EP 3858859, 20251029 | | Publication date | 20210804 | | Priority no. and date | US 201562192396 P, 20150714 | | EP pub. no. and date |
EP 3858859 20210804 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | P87101DK01 | | Inventor | GROSSO, Joseph, Rt. 206&Province Line Road
Princeton, New Jersey 08543, US,
ANDERSON, Jeffrey, Rt. 206&Province Line Road
Princeton, New Jersey 08543, US,
MANEKAS, Demetrios, 14 Yosemite Road
Howell, New Jersey 07731, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C12Q 1/6886 (2018.01) , C12Q 1/70 (2006.01) , G01N 33/574 (2006.01) | | Title | FREMGANGSMÅDE TIL BEHANDLING AF KRÆFT UNDER ANVENDELSE AF EN IMMUN CHECKPOINTINHIBITOR; ANTISTOF SOM BINDER TIL PROGRAMMERET DØD-1 RECEPTOR (PD-1) ELLER PROGRAMMERET DØD LIGAND 1 (PD-L1) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
